Founder of Geodesic Intelligence @Geodesiclab | Professor @UCLA | Opinions are my own

Los Angeles, CA
The future of drug discovery will be built by scientists and AI agents working together. We’re opening up Geodesic’s models and capabilities through APIs, so scientists, developers, and AI agents can build directly on top of them. This is another step toward making AI a native part of how medicines are discovered.
Today, we’re launching the Geodesic API Platform. geodesiclab.com/api For the first time, Geodesic is making our AI models and drug discovery capabilities available through APIs. At its core is NovaAtom, our in-house model for predicting the structures of proteins, small molecules, nucleic acids, and their interactions. Now available in Lite Preview, this is the first time NovaAtom has been made available beyond Geodesic’s own discovery platform. Alongside NovaAtom, we’ve integrated the field’s core models — carefully curated and continuously updated. To use the API: curl -X POST platform.geodesiclab.com/api… \ -H "Authorization: Bearer $GEODESIC_API_KEY" \ -F "model=novaatom" \ -F 'params={"jobName":"rbd-nanobody","sequences":">rbd\nTNLCPFGEVFNATRFASV...\n>nb\nQVQLVESGGGLVQAGGSLR..."}' Poll the job, pull the results, and feed them directly into the next model. Your AI assistant can use the platform directly, too. Connect Claude Code, Codex, or your own agent with one URL and an API key. We manage the integrations and handoffs. You focus on the science. Understand biology. Predict structures. Design proteins. Discover molecules. One key. One interface. Start building today!
3
13
101
220,558
Quanquan Gu retweeted
What does an AI-native workflow for protein binder design look like in practice? In our latest post, we walk through a pilot design run using NovaDDE: Given a target, the AI agent analyzes the design problem, helps select an epitope and design approach, submits the job, and guides the computational evaluation of the resulting candidates. We also share some of the directions we’re exploring as we continue to develop the workflow. A closer look at NovaDDE and where we’re taking it next: geodesiclab.com/news/novadde…
2
16
739
Quanquan Gu retweeted
ʙɪɴᴅᴄʀᴀꜰᴛ2 is out, and we're not waiting for the paper. The full code drops today, free for academic and industry use. We're releasing it early so you can start designing right now, and bring its full power to the current Adaptyv competition. github.com/PacesaLab/BindCra…
30
328
1,480
146,113
Quanquan Gu retweeted
Near-perfect score on the WebMCP benchmark combining Jev with Mercury 2.5! Similar to Mercury 2.5, I suspect Jev itself is a diffusion LLM. Generating structured outputs like JSON in parallel is akin to infilling while sampling from a dLLM.
We just ran Jev on our WebMCP benchmark. The result: basically broke the benchmark. Jev + Mercury 2.5 (a fast, low-cost LLM) using WebMCP solved 100% of the tasks at roughly 112× lower model cost than GPT-6 Astra using computer use with code execution. Compared to Astra using screenshot-based computer use, the model cost was 245× lower (!). We also compared Jev operating the browser with and without WebMCP. We used Browser Use’s open-source Ultrafast, with some improvements to the harness to make it more reliable across the benchmark. Jev’s browser-control accuracy on its own was not amazing - adding WebMCP nearly doubled the number of solved tasks, from 25/49 to 49/49, while reducing model cost by 18% (more on why below). The benchmark and methodology are fully open and reproducible. Full results: webmcp.com/benchmark A few words on how the Jev + WebMCP harness works and why this is exciting: Jev receives text as input and a set of discrete options it can choose from. With WebMCP, those options are the tools exposed by the website. At each step, Jev sees the task, the available tools and previous results, then picks what to do next. The limitation is that Jev can’t generate arbitrary text, which you need for tool arguments. For example, it can choose the search_products tool, but it can’t generate the search query itself. So we split the work: Jev picks the tool and Mercury 2.5 generates the arguments if needed. This works well because turns out most of the cognitive load in these tasks is around choosing the right action. The argument generation itself is relatively simple, so we can delegate to a small and very fast model. We used Mercury, which outputs 1,000+ tokens/sec and is very cheap. The result is a pretty simple combination: Jev for tool selection + Mercury for arguments + WebMCP for the interface. It ends up being very reliable, very fast, and very cheap. A few words about Ultrafast and why do we think it underperforms: Without WebMCP, Jev chooses from the page’s controls: which button to click, which field to fill, or which option to select. But choosing a valid button is different from choosing the right next step. The agent still has to navigate menus, understand forms, recover from errors and recognize when the task is actually complete. Our hypothesis is that WebMCP makes the decision space much simpler. Instead of figuring out a sequence of clicks through a website, Jev chooses explicit actions that directly advance the task. @typesafeai itself documents weaker accuracy on questions requiring multiple reasoning steps. WebMCP moves much of that complexity into the website’s tools, leaving Jev with clearer decisions and fewer opportunities to go wrong (in a sense WebMCP "compresses" a sequence of clicks into one tool call). Our modified Ultrafast setup solved 25/49 tasks - that is a result for our particular implementation and benchmark, not a universal limit on Jev or Browser Use. We are open to more harness optimization to get this result to perform better, feel free to directly contribute to the benchmark here: github.com/nekuda-ai/WindTun… Browser-use ultrafast: github.com/browser-use/jev-u…
8
16
131
10,120
Quanquan Gu retweeted
Our wet-lab validation campaign for Proteina-Complexa is now on bioRxiv! It includes some new exciting experimental results, from large protein structures (fully codesigned!) to functional carbohydrate binders. biorxiv.org/content/10.64898… Thread with some of the additions 🧵1/n
3
47
195
14,147
The future of drug discovery is AI-native. Our goal is to give every scientist the tools to explore more ideas, run more experiments, and discover better medicines faster. NovaDDE Plus is one more step in that direction.
NovaDDE Plus is now live! Built for scientists who use AI for drug discovery every day — more compute, priority access, concurrent runs, API access, and end-to-end campaign execution. $30/month and sign up by September 25 to get your first month free. Our goal is simple: put the most powerful AI for drug discovery into the hands of every scientist. geodesiclab.com/pricing
2
3
73
164,476
honestly the kind of millennium prize problems that are justified.
We’re launching the Geodesic Grand Challenges. What are the hardest questions in drug discovery that, if solved, could change what’s possible over the next 5–10 years? We’re asking you to help define them. Selected questions will become official Geodesic Grand Challenges. Each selected contributor receives 10,000 Geodesic credits. Once the challenges are selected, we’ll open a call for solutions, with a $1 million prize for a verified solution to each challenge. The next breakthrough starts with the right question. Submit yours! geodesiclab.com/grand-challe…
2
26
7,890
Some problems are worth solving as fast as we possibly can. Drug discovery is one of them. Let’s find the hardest problems and solve them together!
We’re launching the Geodesic Grand Challenges. What are the hardest questions in drug discovery that, if solved, could change what’s possible over the next 5–10 years? We’re asking you to help define them. Selected questions will become official Geodesic Grand Challenges. Each selected contributor receives 10,000 Geodesic credits. Once the challenges are selected, we’ll open a call for solutions, with a $1 million prize for a verified solution to each challenge. The next breakthrough starts with the right question. Submit yours! geodesiclab.com/grand-challe…
4
4
157
224,612
This is the direction I’m most excited about for AI for Science: closing the loop between models and real-world experiments!
We built high-throughput materials labs in Menlo Park to create a loop between experiments and models. The labs generate fresh data, the models learn from it, and then help us decide what to try next. Using only 1,300 H200s, plus months of our experimental data, we mid-trained and RL’d an open-source model to surpass GPT-6 Astra on our analysis benchmark. We call it Neon. This is real footage from our lab. We’re focusing first on hard problems in materials science, including superconductors, magnets, and semiconductor materials. Read our blog posts below.
2
4
60
6,708
Quanquan Gu retweeted
I don't trust anyone's AI risk assessment. I don't think we know what awaits us. Given that, I'm choosing to be optimistic, betting an existence more extraordinary than we can imagine sits on the other side and it's worth fighting for.
436
256
6,272
362,770
Well said. Very compact. Sums it all up. I'm optimistic though that while the profession changes, the thirst for knowledge and understanding will not dry up.
One way to frame mathematicians’ concerns about the impact of AI on math: it may lead to the gradual disempowerment of humanity in our ability to understand math because it may degrade the social structures that presently enable that understanding.
1
3
23
3,990
Quanquan Gu retweeted
It’s easy to tell whether Muon was used to train a model just by looking at the empirical spectral distribution of its hidden layer weights. Compared with SGD/Adam, Muon leaves a very distinctive spectral signature in W^T W. This is because Muon updates low-magnitude directions more aggressively.
11
41
633
36,766
Just got this incredible news from UCLA Math Circle. Two high school students, Aayush Bathija and Prince Rohatgi, working with postdoc Daniel Soskin through the UCLA Math Circle, have solved a problem that Fields Medalist June Huh had previously worked on without solving. The paper was heavily AI-assisted. Whatever your view on AI in mathematics, enabling high school students to push the frontier of mathematical research is something worth celebrating. arxiv.org/abs/2609.05341
98
398
3,527
447,934
Mathematicians are increasingly using AI themselves to solve problems. If a problem is genuinely solved, with a rigorous proof that can be independently verified, why should it matter whether the AI was operated by a mathematician, an enthusiast, a university, or an AI company?
Twenty-five Fields Medal winners have published a joint declaration warning about what they see as a severe misalignment between AI companies and the mathematics community.
147
38
533
172,855
To clarify: I deeply respect and admire mathematicians and mathematics. Concerns around data use, attribution, and research norms are valid and should be carefully addressed. My point is that if AI helps produce a rigorous, independently verifiable proof, that is progress for humanity.
10
1,059
I’m happy to see pharma and many leading scientists taking a much more open view of AI for drug discovery. If AI can help us understand biology faster, design better therapeutics, and get medicines to patients years earlier, accelerating discovery is exactly the point. Many problems are just too important to solve slowly.
25 Fields Medalists are worried AI solving math too fast could damage mathematics. I see the opposite happening in coding. Imagine scientists delaying a cancer cure by 100 years just so they can experience discovering it themselves. It would be a disaster for humanity.
8
2
88
9,253
Go to Mars!
Here is a potential roadmap to reversing aging by 2040, created by GPT-6 Pro with Image 2.5. It is important to point out that we will already reach longevity escape velocity by around 2035, so if you can make it to then, you are very likely to live for hundreds of more years!
12
3,348
I’m incredibly excited to finally introduce Geodesic Intelligence @Geodesiclab. We started Geodesic with an ambitious goal: build AGI for drug discovery and find the shortest path from biology to medicines. We’re bringing together frontier AI, biological foundation models, and experimental science, and building the full stack from intelligence to medicines. Today, we’re launching NovaDDE and NovaAtom-Lite-Preview. This is just the beginning.
1/ Today, we’re introducing Geodesic Intelligence, and launching NovaDDE and NovaAtom-Lite-Preview. Geodesic is building an AI-native platform for protein therapeutics, building AGI for drug discovery to find the shortest path from biology to medicines. geodesiclab.com
29
19
329
182,796
Quanquan Gu retweeted
👀 This is really cool! We are accelerating! “AGI for drug discovery to find the shortest path from biology to medicines.”
1/ Today, we’re introducing Geodesic Intelligence, and launching NovaDDE and NovaAtom-Lite-Preview. Geodesic is building an AI-native platform for protein therapeutics, building AGI for drug discovery to find the shortest path from biology to medicines. geodesiclab.com
3
3
37
9,111
Quanquan Gu retweeted
Fantastic new BioAI platform just launched for protein therapeutics, building AGI for drug discovery! Having brief early access was great for trying protein design. Looking forward to this AGI path for drug discovery and synthetic biology. Congrats to @QuanquanGu and the team!
1/ Today, we’re introducing Geodesic Intelligence, and launching NovaDDE and NovaAtom-Lite-Preview. Geodesic is building an AI-native platform for protein therapeutics, building AGI for drug discovery to find the shortest path from biology to medicines. geodesiclab.com
4
63
11,706